Goodwin Procter advised Citrix Systems on the deal. Citrix Systems announced its acquisition by affiliates of Vista Equity Partners and Evergreen Coast Capital Corporation, an affiliate of...
Citrix Systems’ $16.5 Billion Acquisition of Vista Equity Partners and Evergreen Coast Capital’s Affiliates
Naver Corporation’s Acquisition of Poshmark
Goodwin Procter advised Poshmark, Inc. on the deal, while Kirkland & Ellis advised Naver Corp. Poshmark, Inc. (Nasdaq: POSH) announced its definitive agreement to be acquired...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Thoma Bravo’s AUD $1.055 Billion Acquisition of Nearmap
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
908 Devices’ Acquisition of TRACE Analytics GmbH
Goodwin Procter advised 908 Devices on the deal. 08 Devices (Nasdaq: MASS) announced its acquisition of TRACE Analytics GmbH. With the acquisition of TRACE Analytics GmbH, 908...
Amazon.com’s $1.7 Billion Acquisition of iRobot Corporation
Goodwin Procter advised iRobot Corporation on the deal, while Paul, Weiss advised Amazon. iRobot Corporation (NASDAQ: IRBT) announced its definitive agreement to be acquired by Amazon.com, Inc....
HIBio’s License Agreements with MorphoSys AG
Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys. HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR)....
BridgeBio’s $110 Million Sale of Priority Review Voucher
Goodwin Procter advised BridgeBio on the deal. BridgeBio announced its definitive agreement with an undisclosed purchaser to sell its rare pediatric disease Priority Review Voucher for $110...
TA Associates’ Investment in Veracode
Goodwin Procter advised TA Associates on the deal. TA Associates announced its strategic growth investment in Veracode, taking a majority equity position in the business. Veracode is...
Regeneron Pharmaceuticals’ Acquisition of Checkmate Pharmaceuticals
Wachtell, Lipton, Rosen & Katz advised Regeneron on the deal, while Goodwin represented Checkmate Pharmaceuticals. Fried Frank acted as counsel to Centerview Partners, financial advisor to...
Thoma Bravo’s Acquisition of SailPoint Technologies Holdings
Kirkland & Ellis advised Thoma Bravo, while Goodwin Procter advised SailPoint Technologies Holdings, Inc. on the deal. Latham & Watkins represented the direct lenders in the...
Carlyle’s Acquisition of Abingworth
Goodwin Procter and Travers Smith advised Abingworth on the deal, while Debevoise & Plimpton advised Carlyle. Abingworth announced its proposed acquisition by global investment firm Carlyle (NASDAQ:...